معرفی
Dr. Anthony A. Hilliard is a Professor of Medicine in the School of Medicine at Loma Linda University, specializing in Cardiology. He maintains an active clinical and research profile with over 60 publications and leadership in multiple clinical trials. His primary academic appointment is within the Department of Medicine where he contributes to cardiovascular research and medical education.
Education:
- Doctor of Medicine (MD), Loma Linda University, 2002
- Bachelor of Arts (BA), La Sierra University, 1998
Dr. Hilliard's research program focuses on interventional cardiology, heart failure management, and cardiovascular complications across diverse clinical contexts. His work bridges clinical practice and research through investigations of coronary stent systems, medication safety profiles (including SGLT2 inhibitors and minoxidil), and innovative approaches to high-risk cardiac procedures. Recent projects demonstrate growing interest in healthcare systems leadership and metabolic-cardiovascular interactions.
His publication record shows consistent productivity with 15+ publications from 2020-2025, featuring interdisciplinary collaborations across cardiology subspecialties, dermatology, and healthcare administration. Key journals include Cardiovascular Diabetology, Journal of Healthcare Leadership, and JACC: Case Reports, reflecting the clinical and translational nature of his work.
Professional Recognition:
- Fellow of the American College of Cardiology (FACC)
Dr. Hilliard has secured significant research funding as Principal Investigator for industry-sponsored trials with Boston Scientific, AstraZeneca, and Medtronic, plus internal Loma Linda University grants. His current approved project (2025-2026) involves the PK Papyrus Covered Coronary Stent System. As a full Professor, he mentors medical trainees through clinical rotations and research opportunities within the Department of Medicine.
His research is conducted through clinical collaborations within Loma Linda University's Department of Medicine, featuring multidisciplinary teams that include interventional cardiologists, electrophysiologists, and healthcare administrators. Recent work on Blue Zone healthcare leadership demonstrates expansion into health systems research while maintaining core expertise in complex cardiac interventions.
